Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mylan Expects McCain/Schumer To Move In Current Session Of Congress

Executive Summary

Mylan expects legislative efforts for a Waxman/Hatch "fix" via the McCain/Schumer bill to move in the current session of Congress

You may also be interested in...



Bristol De-Lists ABI Taxol Patent Under Settlement With Ivax

Bristol-Myers Squibb is de-listing the American BioSciences paclitaxel patent that threatened the continued marketing of generic versions of Taxol

Bristol De-Lists ABI Taxol Patent Under Settlement With Ivax

Bristol-Myers Squibb is de-listing the American BioSciences paclitaxel patent that threatened the continued marketing of generic versions of Taxol

PDUFA III Or Waxman/Hatch II?: Payors Urge Fix For Generic “Loopholes”

General Motors is among payors urging Congress to address Waxman/Hatch "loophole" legislation as part of the FDA user fee reauthorization bill

Related Content

UsernamePublicRestriction

Register

LL1134044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel